Retatrutide 30mg*10vials

★★★★★5.0 · 1 reviews

Retatrutide 5mg*10vials 132$ 10mg*10vials 158$ 15mg*10vi als 179$ 20mg*10vials 186$ 30mg*10vials 200$ 40mg*10vials 218$ 50mg*10vials 236$ 60mg*10vials 265$ Retatrutide is a new medication to treat obesity, diabetes, and fatty liver disease. During the trial phase, people with obesity who took the highest dose in the study lost an average of 17.5% of their starting weight after nearly six months — halfway through. By week 48, subjects lost more than 24% — an average of 58 lbs. In addition, nearly all 338 adult participants who took lower doses of retatrutide saw a 5%–15% weight reduction. This is significant because many healthcare providers recommend losing 5% to 10% of one's weight over six months to improve blood pressure, cholesterol levels, prediabetes, and metabolic syndrome. Unsurprisingly, in their June 26, 2023 news release addressing retatrutide trial results, announced improvements in blood pressure and blood glucose, cholesterol, and insulin levels at weeks 24 and 48 of the trial. Retatrutide works in three ways: ------------------------------------ Like Wegovy, Mounjaro, and Ozempic, retatrutide helps people lose weight and lower their blood sugar levels. However, Lilly's clinical trials also demonstrated a powerful third outcome with retatrutide. Results showed significant improvement in non-alcoholic fatty liver disease (NAFLD), a common and dangerous problem for people with obesity and metabolic syndrome. Because retatrutide works in three ways, it is considered a "tri-agonist." Dosing Guide: ------------------------ Initial Phase (First 2-4 weeks) = 0.5mg – 1.0mg Titration Phase (Weeks 5-12) = 1.5mg – 2.5mg Maintenance (Weeks 13 and onward) = 2.5mg+ -Patients focusing on weight loss may need higher maintenance doses over time. -Gradual increases are key to reducing fat without causing discomfort.